BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22850020)

  • 1. Translating exome sequencing from research to clinical diagnostics.
    Coonrod EM; Margraf RL; Voelkerding KV
    Clin Chem Lab Med; 2011 Dec; 50(7):1161-8. PubMed ID: 22850020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technological advances in DNA sequence enrichment and sequencing for germline genetic diagnosis.
    Ku CS; Wu M; Cooper DN; Naidoo N; Pawitan Y; Pang B; Iacopetta B; Soong R
    Expert Rev Mol Diagn; 2012 Mar; 12(2):159-73. PubMed ID: 22369376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing genome and exome sequencing for candidate gene identification in inherited disorders: an integrated technical and bioinformatics approach.
    Coonrod EM; Durtschi JD; Margraf RL; Voelkerding KV
    Arch Pathol Lab Med; 2013 Mar; 137(3):415-33. PubMed ID: 22770468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of next generation sequencing on diagnostics in a genetic skin disease clinic.
    Takeichi T; Nanda A; Liu L; Salam A; Campbell P; Fong K; Akiyama M; Ozoemena L; Stone KL; Al-Ajmi H; Simpson MA; McGrath JA
    Exp Dermatol; 2013 Dec; 22(12):825-31. PubMed ID: 24279917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in clinical next-generation sequencing: target enrichment and sequencing technologies.
    Ballester LY; Luthra R; Kanagal-Shamanna R; Singh RR
    Expert Rev Mol Diagn; 2016; 16(3):357-72. PubMed ID: 26680590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities.
    Tetreault M; Bareke E; Nadaf J; Alirezaie N; Majewski J
    Expert Rev Mol Diagn; 2015 Jun; 15(6):749-60. PubMed ID: 25959410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Next-generation DNA sequencing in clinical diagnostics].
    Lacoste C; Fabre A; Pécheux C; Lévy N; Krahn M; Malzac P; Bonello-Palot N; Badens C; Bourgeois P
    Arch Pediatr; 2017 Apr; 24(4):373-383. PubMed ID: 28242148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome sequencing: dual role as a discovery and diagnostic tool.
    Ku CS; Cooper DN; Polychronakos C; Naidoo N; Wu M; Soong R
    Ann Neurol; 2012 Jan; 71(1):5-14. PubMed ID: 22275248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple and efficient identification of rare recessive pathologically important sequence variants from next generation exome sequence data.
    Carr IM; Morgan J; Watson C; Melnik S; Diggle CP; Logan CV; Harrison SM; Taylor GR; Pena SD; Markham AF; Alkuraya FS; Black GC; Ali M; Bonthron DT
    Hum Mutat; 2013 Jul; 34(7):945-52. PubMed ID: 23554237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges.
    de Koning TJ; Jongbloed JD; Sikkema-Raddatz B; Sinke RJ
    Expert Rev Mol Diagn; 2015 Jan; 15(1):61-70. PubMed ID: 25367078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing and its applications in molecular diagnostics.
    Su Z; Ning B; Fang H; Hong H; Perkins R; Tong W; Shi L
    Expert Rev Mol Diagn; 2011 Apr; 11(3):333-43. PubMed ID: 21463242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replicate exome-sequencing in a multiple-generation family: improved interpretation of next-generation sequencing data.
    Cherukuri PF; Maduro V; Fuentes-Fajardo KV; Lam K; ; Adams DR; Tifft CJ; Mullikin JC; Gahl WA; Boerkoel CF
    BMC Genomics; 2015 Nov; 16():998. PubMed ID: 26602380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome.
    Chen MJ; Wei SY; Yang WS; Wu TT; Li HY; Ho HN; Yang YS; Chen PL
    Hum Reprod; 2015 Jul; 30(7):1732-42. PubMed ID: 25924657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding DNA diagnostic panel testing: is more better?
    Klee EW; Hoppman-Chaney NL; Ferber MJ
    Expert Rev Mol Diagn; 2011 Sep; 11(7):703-9. PubMed ID: 21902532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What can exome sequencing do for you?
    Majewski J; Schwartzentruber J; Lalonde E; Montpetit A; Jabado N
    J Med Genet; 2011 Sep; 48(9):580-9. PubMed ID: 21730106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing: capture and sequencing of all human coding regions for disease gene discovery.
    Priya RR; Rajasimha HK; Brooks MJ; Swaroop A
    Methods Mol Biol; 2012; 884():335-51. PubMed ID: 22688718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing.
    Xue Y; Ankala A; Wilcox WR; Hegde MR
    Genet Med; 2015 Jun; 17(6):444-51. PubMed ID: 25232854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and opportunities for next-generation sequencing in companion diagnostics.
    Lin E; Chien J; Ong FS; Fan JB
    Expert Rev Mol Diagn; 2015 Feb; 15(2):193-209. PubMed ID: 25249308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation diagnostics of heritable connective tissue disorders.
    Salam A; Simpson MA; Stone KL; Takeichi T; Nanda A; Akiyama M; McGrath JA
    Matrix Biol; 2014 Jan; 33():35-40. PubMed ID: 23896220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.